Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients-Reference-Cited by-同舟云学术

Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients

Published:2017-08 Issue:5 Volume:98 Page:996-1001
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kim Kelly Y.,Le Quynh-Thu,Yom Sue S.,Ng Raymond H.W.,Chan K.C. Allen,Bratman Scott V.,Welch John J.,Divi Rao L.,Petryshyn Raymond A.,Conley Barbara A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal;Chang;Virus Res,2009

2. The prevalence and prevention of nasopharyngeal carcinoma in China;Cao;Chin J Cancer,2011

3. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma;Mutirangura;Clin Cancer Res,1998

4. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma;Lo;Cancer Res,1999

5. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma;Leung;J Clin Oncol,2006

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma;Scientific Reports;2024-03-28

2. Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection;Infectious Agents and Cancer;2024-03-14

3. Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies;Cancers;2024-02-24

4. Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy;JCO Global Oncology;2024-02

5. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial–mesenchymal transition;Journal of Cancer Research and Clinical Oncology;2023-09-15